Start Date
August 31, 2016
Primary Completion Date
August 31, 2019
Pazopanib
600 mg by mouth daily in a 28 day cycle.
Topotecan
0.25 mg by mouth daily for 21 days of a 28 day cycle.
Phone Call
During follow up if disease gets worse, participant called by study staff every 3 months. Each call should last about 5 minutes.
Collaborators (1)
GlaxoSmithKline
INDUSTRY
M.D. Anderson Cancer Center
OTHER